Day: November 1, 2022

                                                            Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases

• Jeito Capital participates in $120 million financing alongside ARCH Venture Partners and Monograph Capital
  • HI-Bio is a San Francisco-based clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases
  • Investment marks Jeito’s first investment in the United States demonstrating its ambition to build a solid and diversified portfolio of international investments in healthcare companies across therapeutic areas of high unmet need

Paris, France, November 1^st 2022 – Jeito Capital (“Jeito”), a leading independent international private equity firm dedicated to biopharma, announced today that it has participated in the $120 million financing of Human Immunology Biosciences (HI-Bio), a clinical-stage biotech company developing targeted therapies for patients suffering from severe immune-mediated diseases (IMD). Jeito Capital joins a syndicate of world class investors including ARCH Venture Partners and Monograph Capital in backing the San Francisco-based company.

The investment in HI-Bio is Jeito’s 11^th to date and its first in the United States, demonstrating the fund’s ambition to build a global and diverse portfolio of companies operating in numerous therapeutic areas of unmet need for patients and at different stages of development (from pre-clinical to advanced clinical-stage).

HI-Bio has multiple clinical-stage programs and a strong translational platform with the potential to address several diseases with unmet medical needs. Few targeted therapies exist for patients affected by IMDs, which include autoimmune, allergic and inflammatory diseases. Conventional therapies are generally broad-acting and do not address the root cause of disease. As a result, many patients with IMDs experience limited relief from symptoms and may experience unnecessary side effects.

Nearly 4% of the world’s population is potentially affected by one of these diseases, and more than half of those treated with currently available therapies are not in remission. With such large unmet medical patient need, the global therapeutic market for these diseases could reach $150 billion by 2025.

Many IMDs stem from the dysfunction of cells that make up the immune system, including plasma cells, neutrophils, mast cells and more. These cells are responsible for critical functions and processes, including the secretion of antibodies, signaling mediators, and tissue repair and allergic responses. HI-Bio’s programs apply a precision medicine approach to target, modulate or deplete these cellular drivers of disease with therapeutics.

Dr Rafaèle Tordjman, founder and CEO of Jeito, commented: “Jeito’s investment in HI-Bio, alongside distinguished investors such as ARCH Venture Partners and Monograph Capital, represents an important step as we make our first investment in the United States, further demonstrating our ambition to support international companies developing groundbreaking therapies in areas of high unmet need. HI-Bio is launching with a team of renowned experts with impressive track records and a pipeline of precision therapies that have the potential to address unmet patient needs around the world today.”

Rachel Mears, Partner at Jeito, added: “Jeito’s investment supports the important work by HI-Bio on behalf of patients suffering from immune-mediated diseases. The potential to reduce the enormous health burden for these patients using HI-Bio’s precision medicine approach was a key motivator for this investment. With HI-Bio’s ongoing clinical programs and its strong pipeline of additional development candidates, Jeito’s strategy to invest behind strong teams founded on great science and positioned for growth driven by making a difference for patients fits hand-in-hand with HI-Bio.”

Travis Murdoch, M.D., CEO of HI-Bio concluded: “We at HI-Bio are an embodiment of the urgent need to develop precision therapies that are more targeted for patients suffering from immune-mediated diseases. Immune-mediated diseases represent a landscape where the scale of unmet need and potential patient benefit is truly enormous. We are grateful to our investors Jeito Capital, ARCH and Monograph who share our vision for HI-Bio. They see that we have an actionable opportunity to bring an unprecedented degree of precision and creativity to clinical immunology, with all the potential safety and efficacy enhancements that come with our approach.”

About Jeito Capital
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients’ access globally, especially in Europe and the United States. Jeito Capital has €534 million under management and a rapidly growing portfolio of investments. Jeito Capital is based in Paris with a presence in Europe and the United States.

@Jeito_lifeLinkedIn For more information, please visit www.jeito.life, or follow @Jeito_life on Twitter or LinkedIn.

For further information please contact :

Jeito Capital
Rafaèle Tordjman
Assia Mouhout, PA
assia@jeito.life
Tel : +33 6 76 49 37 94

Consilium Strategic Communications

Mary-Jane Elliott / Davide Salvi / Kris Lam

Jeito@consilium-comms.com

Tel: +44 (0) 20 3709 5700

Attachment

• 20221101_CP Jeito investit dans HI-Bio

Anglepoint expands its UK footprint, accelerates EMEA revenue growth

SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) — Anglepoint, the leading provider of Software Asset Management (SAM) Managed Services for the Global 2000, is announcing the completed acquisition of UK-based Fisher Information Technology Services (FisherITS). FisherITS brings a 10-year track record of providing high-quality SAM consulting and Managed Services to large and midsize clients in the UK, USA, Canada, and EMEA.

Anglepoint CEO Brian Papay says of the acquisition, “The successful completion of this deal is a testament to the high-caliber organization that FisherITS has created. Anglepoint is committed to expanding our presence in the EMEA region. Adding the deep expertise of the FisherITS team, their outstanding partners, and long-time clients only bolsters Anglepoint’s momentum.”

The FisherITS team will join Anglepoint, bringing industry-leading clients, worldwide channel partners and the intellectual platform OpenSAM, FisherITS’s SaaS-based BI automation solution. “Large enterprises are increasingly seeing the need and benefit of SAM Managed Services. Anglepoint has more than tripled since 2017, and that growth is because of the strong value that high-quality SAM services provide to our clients,” adds Brian Papay.

Eric Chiu, founder and Managing Director of FisherITS, says, “FisherITS’s DNA of focusing on business value, deep vendor expertise and automation is very similar to Anglepoint’s. In addition to expanding our geographical service coverage, our global clients and partners can now leverage added areas of expertise such as SAM tooling, cloud cost management (FinOps) and information security.”

ABOUT ANGLEPOINT 

Anglepoint is the leading provider of Software Asset Management & Technology Asset Management services to the Fortune 500 & Global 2000. Anglepoint’s services drive cost optimization, risk mitigation, & strategic planning within the cloud, SaaS, enterprise software & hardware estates of complex hybrid IT environments. Anglepoint delivers comprehensive managed services, including SAM strategy, execution, process automation, and technology selection & implementation.

For media inquiries, please contact: Alison Frederick, Analyst Relations at info@anglepoint.com.

Connect with Anglepoint on LinkedIn, Facebook, Twitter, and at Anglepoint.com.

ABOUT FISHER INFORMATION TECHNOLOGY SERVICES

FisherITS provides Software Asset Management consultancy and managed services to large and fast-growing organisations across the world. Specialising in audit support, software optimisation and ITAM programme implementation, FisherITS provides expertise across all leading software publishers such as Microsoft, IBM, SAP, Oracle, Quest and Micro Focus.

OpenSAM is a SaaS-based automation platform built by FisherITS to deliver SAM-related business intelligence to its Managed Services clients.

Connect with FisherITS on LinkedIn and at FisherITS.com.

Contact Information:
Alison Frederick
Analyst Relations Manager
info@anglepoint.com

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Featured Image for Anglepoint

GlobeNewswire Distribution ID 8686036

JOHANNESBURG, South Africa, Nov. 01, 2022 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Absa Bank Limited (Absa), a leading African bank, has selected the nCino Bank Operating System^®, to deliver a single platform solution to automate its debt case management and portfolio reporting processes in its Relationship Banking Business.

As the bank accelerates its digitization programme, nCino will deliver this cloud-based platform and help Absa reduce complexity and eliminate high-touch processes, ultimately enhancing its employee and customer experience and improving efficiency.

“The introduction of nCino will provide Absa with a single centralized workflow solution, which will streamline its internal processes,” said Kate Jane Johnsen, Regional Vice President at nCino. “I am eager to see the results of this partnership in action.”

“We are confident that the nCino platform will support our ambitions to be a digitally powered business,” said Sugandree Mudely from Absa Relationship Banking. “The delivery of this solution is a meaningful milestone in our digital transformation.”

About nCino
nCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. The nCino Bank Operating System^® empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost savings and regulatory compliance. In a digital-first world, nCino’s single cloud-based platform enhances the employee and client experience to enable financial institutions to more effectively onboard clients, make loans and manage the entire loan life cycle, and open deposit and other accounts across lines of business and channels. Transforming how financial institutions operate through innovation, reputation and speed, nCino is partnered with more than 1,750 financial institutions of all types and sizes on a global basis. For more information, visit www.ncino.com.

About Absa Bank Limited
Absa Bank Limited (‘Absa Bank’) is a wholly-owned subsidiary of Absa Group Limited, which is listed on the Johannesburg Stock Exchange and is one of Africa’s largest financial services groups. Absa offers a range of retail, business, corporate and investment banking and wealth management and insurance products and services primarily in South Africa and Namibia.

For further information about Absa, please visit our website www.absa.co.za

Media Contacts

EMEA
Natalia Moose, nCino
+44 7825 211135
natalia.moose@ncino.com

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally include actions, events, results, strategies and expectations and are often identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. Any forward-looking statements contained in this press release are based upon nCino’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent nCino’s expectations as of the date of this press release. Subsequent events may cause these expectations to change and, except as may be required by law, nCino does not undertake any obligation to update or revise these forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially including, among others, risks and uncertainties relating to the market adoption of our solution and privacy and data security matters. Additional risks and uncertainties that could affect nCino’s business and financial results are included in reports filed by nCino with the U.S. Securities and Exchange Commission (available on our web site at www.ncino.com or the SEC’s web site at www.sec.gov). Further information on potential risks that could affect actual results will be included in other filings nCino makes with the SEC from time to time.

GlobeNewswire Distribution ID 8685731

TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) — Virgo Group of Companies, the holding body of Canada’s regulated cryptocurrency trading platform VirgoCX Inc. is going global by bringing its commission-free trading platform to Australia. The company is registered with Australian Transaction Reports and Analysis Centre (AUSTRAC) and has become available for users to buy and sell 60+ cryptocurrencies.

“Australia is a fast-growing market with increasing crypto adoption and mature real-time bank transfers. I was excited to see the passionate and strong community during the visit several weeks ago,” said Adam Cai, CEO of Virgo Group. “Virgo group fully trusts in the potential of Australian market and looks forward to this new chapter.”

Based in Toronto, Ontario, VirgoCX is one of the most trusted crypto trading platforms in Canada. Under the highly competent leadership team, the platform grew immensely in the past few years and became a key contributor to Canada’s crypto adoption by lowering the barriers and costs for entering the crypto markets, providing helpful trading tools with a beginner-friendly user interface, and taking a proactive approach to regulations to ensure consumers protection. It is one of the few companies in Canada that obtained the Restricted Dealer license from Canadian Securities Administrators (CSA). These ceaseless efforts have brought a record 1,700% year-on-year increase in trading volume from 2020 to 2021 with the total trading amount exceeding CAD $1 billion.

Albeit the bearish market sentiment, the firm affirms its mission to accelerate global crypto adoption by entering Australia. Virgo stands firm behind its belief in cryptocurrencies and other digital assets and strive to provide quality services for Australians to enjoy. It has officially launched the commission-free trading platform that offers a large selection of popular cryptocurrencies, free AUD & Crypto deposits and withdrawals, instant funding with PayID & BSB, as well as tight spreads on coin prices. It will soon introduce more comprehensive services, including staking and earning products. Virgo will keep innovating with a compliant approach to bring a trusted and transparent platform to Australian crypto users.

The firm’s expansion to Australia is crucial for driving global crypto adoption. According to Finder’s Crypto Adoption Index, Australia has the fourth highest rate of crypto adoption in the world. The country also has a forward-looking government determined to establish crypto regulations while encouraging technological innovation.

Virgo Group is set to emulate the success it has seen in Canada and become the trusted full-service solution for all things cryptocurrency to all Australians.

About Virgo Group

Virgo Group of Companies is dedicated to providing commission-free crypto trading services globally. It covers multiple business lines, including retail fiat to crypto trading, crypto wealth management, NFT liquidity management, and more. With continuous innovation in mind, Virgo Group is prepared to become an integrated global digital asset service provider.

Media Contact 

Nora Anwar
Marketing Manager
nora.anwar@virgo.co

Contact Information:
Nora Anwar
Marketing Manager
nora.anwar@virgo.co
+16472177219

Related Images

Image 1: Virgo.co

Virgo.co

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Virgo.co

GlobeNewswire Distribution ID 8685253

SINGAPORE, Nov. 01, 2022 (GLOBE NEWSWIRE) — Singapore-based technology asset lifecycle services company TES and 3DOM (Singapore), the Singapore office of Japan-based battery producer 3DOM Alliance Inc., have signed a Memorandum of Understanding (MOU) to work together to develop and grow Singapore’s battery recycling and manufacturing ecosystem.

The agreement was facilitated in part by the Singapore Battery Consortium (SBC). As the MOU moves forward, it will likely also involve battery solutions provided by Singapore-based GenPlus.

3DOM (Singapore) is responsible for the production and supply of lithium-ion batteries developed in Japan by 3DOM Alliance Inc., with a presence in mobility and energy storage applications.

This partnership investigates collaboration opportunities pertaining to 1) lithium-ion battery recycling services in Singapore; 2) the synergies between TES and 3DOM in their roles in end-of-life battery management in the region; and 3) energy storage system (ESS) integration opportunities to increase the sustainability of electrification in Singapore’s increasingly circular economy.

The MOU allows both companies to work together towards the listed goals. Additionally, TES will offer recycling services to 3DOM for the lithium-ion batteries it generates in the region. The two companies will also explore synergies between portfolio companies for repurposing and reusing batteries.

“This MOU represents 3DOM (Singapore)’s commitment to Singapore’s vision of a circular economy for batteries and the future of technology. We have confidence that with TES, we have the right partner to move forward with the responsible handling, repurposing, and recycling of batteries and battery materials in Singapore,” said Mari Matsushita, Chief Product Officer of 3DOM (Singapore).

David Lee, Chief Strategy Officer of TES, added, “We are delighted to have been selected by 3DOM (Singapore) to be their partner in recycling and closing the loop here in Singapore. This MOU represents what we are certain will be the first of many positive steps in creating a closed-loop system for battery materials in Singapore and the wider region.”

For more information about TES, visit https://www.tes-amm.com/.

Additional information about innovative battery technology and energy solutions provider 3DOM (Singapore) can be found at https://3dom.sg. For further information, please contact garry.tay@3dom.co.jp.

Contact Information:
Eric Ingebretsen
Chief Commercial Officer
eric.ingebretsen@tes-amm.com
+6564088660

This content was issued through the press release distribution service at Newswire.com.

GlobeNewswire Distribution ID 8686157